Login
$VTGN
$0.17 +$0.00 (0.12%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jun 30, 2026
Q4 FY2026
As of Mar 31, 2026
Q3 FY2026
As of Dec 31, 2025
Q2 FY2026
As of Sep 30, 2025
Q1 FY2026
As of Jun 30, 2025
Q4 FY2025
As of Mar 31, 2025
Q3 FY2025
As of Dec 31, 2024
Q2 FY2025
As of Sep 30, 2024
Q1 FY2025
As of Jun 30, 2024
Q4 FY2024
As of Mar 31, 2024
Q3 FY2024
As of Dec 31, 2023
Q2 FY2024
As of Sep 30, 2023
Q1 FY2024
As of Jun 30, 2023
Q4 FY2023
As of Mar 31, 2023
Q3 FY2023
As of Dec 31, 2022
Q2 FY2023
As of Sep 30, 2022
Q1 FY2023
As of Jun 30, 2022
Q4 FY2022
As of Mar 31, 2022
Q3 FY2022
As of Dec 31, 2021
Q2 FY2022
As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Marketable securities
Prepaid expenses and other current assets
Deferred contract acquisition costs - current portion
Total current assets
Property and equipment, net
Right-of-use asset - operating lease
Deferred offering costs
Deferred contract acquisition costs - non-current portion
Security deposits
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses
Note payable
Collaborative Arrangement
Total note payable
Deferred revenue
Operating lease obligation - current portion
Financing lease obligation - current portion
Total current liabilities
Deferred revenue - non-current portion
Operating lease obligation - non-current portion
Financing lease obligation - non-current portion
Total non-current liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized at June 30, 2026 and March 31, 2026; no shares outstanding at June 30, 2026 and March 31, 2026
Total preferred stock, $0.001 par value; 10,000,000 shares authorized at June 30, 2026 and March 31, 2026; no shares outstanding at June 30, 2026 and March 31, 2026
Common stock, $0.001 par value; 325,000,000 shares authorized at June 30, 2026 and March 31, 2026; 44,381,433 and 39,624,839 shares issued at June 30, 2026 and March 31, 2026, respectively
Total common stock, $0.001 par value; 325,000,000 shares authorized at June 30, 2026 and March 31, 2026; 44,381,433 and 39,624,839 shares issued at June 30, 2026 and March 31, 2026, respectively
Additional paid-in capital
Treasury stock, at cost, 4,522 shares of common stock held at June 30, 2026 and March 31, 2026
Accumulated other comprehensive income
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support